Shares of Philip Morris International Inc. extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the marketing of 20 of the tobacco company’s Zyn nicotine ...

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from ...

Philip Morris delivered strong Q4 results, driven by surging demand for products like IQOS and ZYN. Read why I maintain a ...

Philip Morris International Inc. (PM)'s share was trading at $119.80 as of Jan 16 th. PM’s trailing and forward P/E were 19.02 and 17.24 respectively according to Yahoo Finance.

Overall, the quarter highlighted Philip Morris's strategic shift towards smoke-free products, supporting a strong financial performance despite lingering reliance on traditional tobacco products.

Feb 6 (Reuters) - Cigarette giant Philip Morris International (PM.N), opens new tab on Thursday forecast better-than-expected profit growth for 2025, with estimations for its fast-growing nicotine ...

Philip Morris (NYSE:PM) is set to report fourth quarter earnings on Thursday, and investors’ focus will be on the global tobacco giant’s smoke-free products (SFPs) business as health-conscious ...

Philip Morris International Inc. PM is likely to register top and bottom-line growth when it reports fourth-quarter 2024 earnings on Feb. 6. The Zacks Consensus Estimate for revenues is pegged at ...